← Eichor
Study identifier: NCT06886815 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Popliteal Nerve Block for Acute Achilles Tendon Rupture Repair Surgery

Condition: Acute Achilles Tendon Rupture  ·  Sponsor: Women's College Hospital

PhaseNA
Planned participants80
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Achilles tendon rupture is common, yet the value of popliteal nerve block for postoperative pain control during surgical repair remains uncertain. Despite widespread use, evidence supporting its analgesic effectiveness is limited, and both popliteal nerve block and Achilles tendon repair carry risks of nerve injury. This randomized, placebo-controlled trial will evaluate whether adding a popliteal nerve block to standard systemic analgesia improves postoperative pain and reduces opioid use in patients undergoing acute Achilles tendon rupture repair. Secondary outcomes will examine the incidence and impact of nerve complications on recovery, including return to physical activity and functional performance.

This description comes directly from the study's public registry record.

Talk to the study team

Didem Bozak  ·  416-323-6008  ·  didem.bozak@wchospital.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Women's College HospitalToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06886815